{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:01:12Z","timestamp":1791234072225,"version":"4.1.0"},"reference-count":121,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The growing burden of metabolic disorders manifested by hypertension, type 2 diabetes mellitus, hyperlipidemia, obesity and non-alcoholic fatty liver disease presents a significant global health challenge by contributing to cardiovascular diseases and high mortality rates. \u0392-blockers are among the most widely used drugs in the treatment of hypertension and acute cardiovascular events. In addition to blocking the receptor sites for catecholamines, third-generation \u03b2-blockers with associated vasodilating properties, such as carvedilol and nebivolol, provide a broad spectrum of metabolic effects, including anti-inflammatory and antioxidant properties and a favorable impact on glucose and lipid metabolism. This review aims to report the impact of \u03b2-blockers on metabolic modulation based on available literature data. We present an overview of \u03b2-blockers and their pleiotropic properties, discuss mechanisms by which these drugs affect cellular metabolism and outline the future perspectives. The influence of \u03b2-blockers on glucose metabolism, insulin sensitivity, inflammation and oxidative stress is complex and varies depending on the specific \u03b2-blocker used, patient population and underlying health conditions. Recent evidence particularly highlights the potential role of vasodilatory and nitric oxide-mediated properties of nebivolol and carvedilol in improving glycemic control, insulin sensitivity, and lipid metabolism and mitigating oxidative stress and inflammation. It suggests that these drugs may be potential therapeutic options for patients with metabolic disorders, extending beyond their primary role in cardiovascular management.<\/jats:p>","DOI":"10.3389\/fphar.2024.1489657","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T06:30:54Z","timestamp":1734676254000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["\u03b2-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress"],"prefix":"10.3389","volume":"15","author":[{"given":"Szymon","family":"Dryga\u0142a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Radzikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Maciejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2165\/00003495-200767080-00001","article-title":"Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics","volume":"67","author":"Agabiti Rosei","year":"2007","journal-title":"Drugs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"749291","DOI":"10.3389\/fimmu.2021.749291","article-title":"Effects of \u03b2-blockers on the sympathetic and cytokines storms in covid-19","volume":"12","author":"Al-Kuraishy","year":"2021","journal-title":"Front. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.intimp.2022.109119","article-title":"Carvedilol attenuates brain damage in mice with hepatic encephalopathy","volume":"111","author":"Amirshahrokhi","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.12968\/bjca.2018.13.10.491","article-title":"Beta-blocker use in cardiovascular disease","volume":"13","author":"Bain","year":"2018","journal-title":"Br. J. Card. Nurs."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12872-018-0858-5","article-title":"Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries","volume":"18","author":"Bazargani","year":"2018","journal-title":"BMC Cardiovasc. Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s00044-011-9781-3","article-title":"Theoretical study on some non-selective beta-adrenergic antagonists and correlation to their biologically active configurations","volume":"21","author":"Bekhradnia","year":"2012","journal-title":"Med. Chem. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","article-title":"Nrf2\u2013are pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"157","author":"Buend\u00eda","year":"2016","journal-title":"Pharmacol. and Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2284486","DOI":"10.1080\/2162402x.2023.2284486","article-title":"Trial watch: beta-blockers in cancer therapy","volume":"12","author":"Carnet Le Provost","year":"2023","journal-title":"OncoImmunology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0216828","DOI":"10.1371\/journal.pone.0216828","article-title":"The effect of propranolol on the prognosis of hepatocellular carcinoma: a nationwide population-based study","volume":"14","author":"Chang","year":"2019","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.36876\/smabt.1008","article-title":"Method development and validation for the determination of pravastatin in human plasma by lc-ms\/ms","volume":"2","author":"Chen","year":"2017","journal-title":"SM Anal. Bioanal. Tech."},{"key":"B12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/jhh.2017.8","article-title":"Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage","volume":"31","author":"Coats","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"B13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/eurjhf\/hfs060","article-title":"Heart rate achieved or beta-blocker dose in patients with chronic heart failure: which is the better target?","volume":"14","author":"Cullington","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"B15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1751-7176.2010.00386.x","article-title":"Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating \u03b2-blockers","volume":"13","author":"Deedwania","year":"2011","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jama.2024.8771","article-title":"Bisoprolol in patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS randomized clinical trial","volume":"332","author":"Devereux","year":"2024","journal-title":"Jama"},{"key":"B17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.22543\/7674.62.P216223","article-title":"Beta-blockers in cardiovascular therapy: a review","volume":"6","author":"Diaconu","year":"2019","journal-title":"J. Mind Med. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1161\/hypertensionaha.115.06979","article-title":"Chronic nebivolol treatment suppresses endothelin-1\u2013mediated vasoconstrictor tone in adults with elevated blood pressure","volume":"67","author":"Diehl","year":"2016","journal-title":"Hypertension"},{"key":"B19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12931-017-0609-7","article-title":"Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)","volume":"18","author":"Duffy","year":"2017","journal-title":"Respir. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"109181","DOI":"10.1016\/j.cbi.2020.109181","article-title":"Carvedilol attenuates l-arginine induced acute pancreatitis in rats through modulation of oxidative stress and inflammatory mediators","volume":"327","author":"El Morsy","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"B21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/ddr.21256","article-title":"Carvedilol attenuates inflammatory biomarkers and oxidative stress in a rat model of ulcerative colitis","volume":"76","author":"Fatani","year":"2015","journal-title":"Drug Dev. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s40265-015-0435-5","article-title":"A review of nebivolol Pharmacology and clinical evidence","volume":"75","author":"Fongemie","year":"2015","journal-title":"Drugs"},{"key":"B23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B24","doi-asserted-by":"publisher","first-page":"104587","DOI":"10.1016\/j.phrs.2019.104587","article-title":"\u03b2-blockers: their new life from hypertension to cancer and migraine","volume":"151","author":"Fumagalli","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/08860220802353900","article-title":"Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats","volume":"30","author":"Gandhi","year":"2008","journal-title":"Ren. Fail."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/exd.13706","article-title":"Gromwell (lithospermum erythrorhizon) root extract protects against glycation and related inflammatory and oxidative stress while offering uv absorption capability","volume":"27","author":"Glynn","year":"2018","journal-title":"Exp. Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/ac.65.5.2056244","article-title":"Beta-blockers: focus on mechanism of action. Which beta-blocker, when and why?","volume":"65","author":"Gorre","year":"2010","journal-title":"Acta Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1524","DOI":"10.1097\/MJT.0000000000000200","article-title":"Beta blockers suppress dextrose-induced endoplasmic reticulum stress, oxidative stress, and apoptosis in human coronary artery endothelial cells","volume":"23","author":"Haas","year":"2016","journal-title":"Am. J. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/circulationaha.115.018580","article-title":"Long-term effectiveness and safety of pravastatin in patients with coronary heart disease: sixteen years of follow-up of the LIPID study","volume":"133","author":"Hague","year":"2016","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1038\/cddiscovery.2015.19","article-title":"Pro-survival function of MEF2 in cardiomyocytes is enhanced by \u03b2-blockers","volume":"1","author":"Hashemi","year":"2015","journal-title":"Cell Death Discov."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1177\/0960327121999442","article-title":"Role of TLR-4\/IL-6\/TNF-\u03b1, COX-II and eNOS\/iNOS pathways in the impact of carvedilol against hepatic ischemia reperfusion injury","volume":"40","author":"Hassan","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.3892\/ol.2017.6653","article-title":"Activation of \u03b2-adrenergic receptor promotes cellular proliferation in human glioblastoma","volume":"14","author":"He","year":"2017","journal-title":"Oncol. Lett."},{"key":"B33","doi-asserted-by":"publisher","first-page":"E202","DOI":"10.1152\/ajpendo.00394.2009","article-title":"Endothelial function in subjects with isolated low hdl cholesterol: role of nitric oxide and circulating progenitor cells","volume":"298","author":"Higashi","year":"2010","journal-title":"Am. J. Physiology-Endocrinology Metabolism"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3329\/uhj.v14i1.38478","article-title":"A comparative study of bisoprolol with carvedilol on LV systolic function in patients with chronic heart failure","volume":"14","author":"Hossain","year":"2018","journal-title":"Univ. Heart J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.cjca.2014.03.003","article-title":"Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease","volume":"30","author":"Howlett","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/HJH.0000000000003109","article-title":"Nebivolol and incident cardiovascular events in hypertensive patients compared with nonvasodilatory beta blockers","volume":"40","author":"Huck","year":"2022","journal-title":"J. Hypertens."},{"key":"B37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ijcard.2009.09.551","article-title":"The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion","volume":"147","author":"Ib\u00e1\u00f1ez","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/0960327114527628","article-title":"Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats","volume":"33","author":"Imbaby","year":"2014","journal-title":"Hum. Exp. Toxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"16504","DOI":"10.1096\/fj.202001743r","article-title":"Protective effects of pravastatin on the embryonic cardiovascular system during hypoxic development","volume":"34","author":"Itani","year":"2020","journal-title":"FASEB J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/life11010060","article-title":"The role of oxidative stress in cardiovascular aging and cardiovascular diseases","volume":"11","author":"Izzo","year":"2021","journal-title":"Life (Basel, Switz.)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3390\/ijms21051897","article-title":"Pravastatin alleviates radiation proctitis by regulating thrombomodulin in irradiated endothelial cells","volume":"21","author":"Jang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00540-009-0865-x","article-title":"Possible indications of beta-blockers in the perioperative period other than prevention of cardiac ischemia","volume":"24","author":"Kadoi","year":"2010","journal-title":"J. Anesth."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1016\/j.bmc.2006.05.065","article-title":"Synthesis and biological evaluation of benzopyran analogues bearing class III antiarrhythmic pharmacophores","volume":"14","author":"Koufaki","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2165\/00129784-200606040-00001","article-title":"Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol","volume":"6","author":"Kveiborg","year":"2006","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"B45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1755-5922.2011.00306.x","article-title":"Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity","volume":"31","author":"Ladage","year":"2013","journal-title":"Cardiovasc. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"27559","DOI":"10.1021\/acsomega.4c03025","article-title":"Novel properties of old propranolol-assessment of antiglycation activity through in vitro and in silico approaches","volume":"9","author":"Lauko","year":"2024","journal-title":"ACS Omega"},{"key":"B47","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.devcel.2006.09.006","article-title":"Klf2 is an essential regulator of vascular hemodynamic forces in vivo","volume":"11","author":"Lee","year":"2006","journal-title":"Dev. Cell."},{"key":"B48","doi-asserted-by":"publisher","first-page":"E242","DOI":"10.1152\/ajpendo.1994.266.2.e242","article-title":"Acute noradrenergic activation induces insulin resistance in human skeletal muscle","volume":"266","author":"Lembo","year":"1994","journal-title":"Am. J. Physiology-Endocrinology Metabolism"},{"key":"B49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/cimb43010020","article-title":"Pancreatic islets exhibit dysregulated adaptation of insulin secretion after chronic epinephrine exposure","volume":"43","author":"Li","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"113057","DOI":"10.1016\/j.biopha.2022.113057","article-title":"Beneficial effects of carvedilol modulating potassium channels on the control of glucose","volume":"150","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"CD001946","DOI":"10.1002\/14651858.CD001946.pub2","article-title":"Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia","volume":"2004","author":"Lima","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/cells9061373","article-title":"Effects of \u03b2-adrenergic blockade on metabolic and inflammatory responses in a rat model of ischemic stroke","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/08037059209077499","article-title":"Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients","volume":"1","author":"Lithell","year":"1992","journal-title":"Blood Press."},{"key":"B54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/jdi.14147","article-title":"Oxidative stress suppresses phb2\u2010mediated mitophagy in \u03b2\u2010cells via the nrf2\/phb2 pathway","volume":"15","author":"Liu","year":"2024","journal-title":"J. Diabetes Investigation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.3892\/mmr.2015.4149","article-title":"Pravastatin inhibits fibrinogen- and fdp-induced inflammatory response via reducing the production of il-6, tnf-\u03b1 and inos in vascular smooth muscle cells","volume":"12","author":"Lu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1007\/BF00207613","article-title":"Long-term hemodynamic effects of antihypertensive treatment","volume":"70","author":"Lund-Johansen","year":"1992","journal-title":"Clin. investigator"},{"key":"B57","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/jcm9020497","article-title":"Salivary redox biomarkers in selected neurodegenerative diseases","volume":"9","author":"Maciejczyk","year":"2020","journal-title":"J. Clin. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbe.2017.05.001","article-title":"The autonomic nervous system and cancer","volume":"37","author":"Makale","year":"2017","journal-title":"Biocybern. Biomed. Eng."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.metabol.2011.04.009","article-title":"Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat","volume":"60","author":"Manrique","year":"2011","journal-title":"Metabolism"},{"key":"B60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11906-017-0716-3","article-title":"Differential metabolic effects of beta-blockers: an updated systematic review of nebivolol","volume":"19","author":"Marketou","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1021\/jf990872o","article-title":"Measurement of food flavonoids by high-performance liquid chromatography: a review","volume":"48","author":"Merken","year":"2000","journal-title":"J. Agric. Food Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s43044-020-00099-5","article-title":"Effect of carvedilol versus nebivolol on insulin resistance among non-diabetic, non-ischemic cardiomyopathy with heart failure","volume":"72","author":"Metwally","year":"2020","journal-title":"Egypt. Heart J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1161\/01.ATV.0000065234.70518.26","article-title":"Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells","volume":"23","author":"Mollnau","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.2147\/ott.s167422","article-title":"The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients","volume":"11","author":"Na","year":"2018","journal-title":"OncoTargets Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"953749","DOI":"10.3389\/fmed.2022.953749","article-title":"Treatment with \u03b2-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats","volume":"9","author":"Nascimento","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.19080\/crdoj.2018.08.555737","article-title":"The effect of statins on type ii diabetes mellitus","volume":"8","author":"Nayak","year":"2018","journal-title":"Curr. Res. Diabetes and Obes. J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1293295","DOI":"10.3389\/fphar.2023.1293295","article-title":"Preliminary evaluation of the antiglycoxidant activity of verapamil using various in vitro and in silico biochemical\/biophysical methods","volume":"14","author":"Nesterowicz","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1042\/bcj20160503c","article-title":"Molecular mechanisms of ros production and oxidative stress in diabetes","volume":"473","author":"Newsholme","year":"2016","journal-title":"Biochem. J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/s0024-3205(96)00596-6","article-title":"Role of central neural mechanisms in the regulation of hepatic glucose metabolism","volume":"60","author":"Nonogaki","year":"1997","journal-title":"Life Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/j.2055-2335.2007.tb00027.x","article-title":"Lipophilicity of beta\u2010adrenocepter antagonists: a new classification scheme for clinical use","volume":"37","author":"Northfield","year":"2007","journal-title":"J. Pharm. Pract. Res."},{"key":"B71","volume-title":"Cardiovascular disease","author":"Olvera Lopez","year":"2023"},{"key":"B72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/1074248416644987","article-title":"Effects of carvedilol compared to nebivolol on insulin resistance and lipid profile in patients with essential hypertension","volume":"22","author":"Ozyildiz","year":"2017","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11906-007-0050-2","article-title":"The vasodilatory beta-blockers","volume":"9","author":"Pedersen","year":"2007","journal-title":"Curr. Hypertens. Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/ph13060105","article-title":"Beta-blockers and cancer: where are we?","volume":"13","author":"Peixoto","year":"2020","journal-title":"Pharm. (Basel)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1467-789x.2001.00044.x","article-title":"Use of beta-blockers in obesity hypertension: potential role of weight gain","volume":"2","author":"Pischon","year":"2001","journal-title":"Obes. Rev."},{"key":"B76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s13311-018-0614-7","article-title":"Targeted nitric oxide synthase inhibitors for migraine","volume":"15","author":"Pradhan","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2298\/mpns2104129p","article-title":"Use of beta blockers in patients with asthma and chronic obstructive pulmonary disease","volume":"74","author":"Preveden","year":"2021","journal-title":"Med. Pregl."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/hypertensionaha.113.01302","article-title":"Differential effects of nebivolol versus metoprolol on functional sympatholysis in hypertensive humans","volume":"61","author":"Price","year":"2013","journal-title":"Hypertension"},{"key":"B79","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0091270007310378","article-title":"Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker","volume":"48","author":"Prisant","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11916-004-0022-z","article-title":"Prophylactic migraine therapy: mechanisms and evidence","volume":"8","author":"Ramadan","year":"2004","journal-title":"Curr. Pain Headache Rep."},{"key":"B81","doi-asserted-by":"publisher","first-page":"015401","DOI":"10.1088\/1361-6463\/ac2530","article-title":"Effect of pulsed electric field on diabetes-induced glycated enzyme, oxidative stress, and inflammatory markers in vitro and in vivo","volume":"55","author":"Rezaeinezhad","year":"2021","journal-title":"J. Phys. D Appl. Phys."},{"key":"B82","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/107424840300800206","article-title":"The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study","volume":"8","author":"Rizos","year":"2003","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"B83","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1179\/135100005X38879","article-title":"Cytoprotective effects of carvedilol against oxygen free radical generation in rat liver","volume":"10","author":"Ronsein","year":"2005","journal-title":"Redox. Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3109\/08037059709086442","article-title":"Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture","volume":"6","author":"Saijonmaa","year":"1997","journal-title":"Blood Press."},{"key":"B85","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1046\/j.1526-4610.2000.00005.x","article-title":"Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials","volume":"40","author":"Sandor","year":"2000","journal-title":"Headache"},{"key":"B86","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1524-6175.2005.04679.x","article-title":"Do the metabolic effects of \u03b2 blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?","volume":"8","author":"Sarafidis","year":"2006","journal-title":"J. Clin. Hypertens."},{"key":"B87","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/apt.16242","article-title":"Editorial: non-selective beta blockers-in and out of circulation. Authors' reply","volume":"53","author":"Sasso","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/00004647-200008000-00005","article-title":"The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke","volume":"20","author":"Savitz","year":"2000","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e002272","DOI":"10.1161\/JAHA.115.002272","article-title":"Increased heme levels in the heart lead to exacerbated ischemic injury","volume":"4","author":"Sawicki","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"B90","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1161\/01.cir.96.11.4104","article-title":"Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity","volume":"96","author":"Scherrer","year":"1997","journal-title":"Circulation"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B92","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12933-023-01862-z","article-title":"Identification of candidate metabolite biomarkers for metabolic syndrome and its five components in population-based human cohorts","volume":"22","author":"Shi","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e1801655","DOI":"10.1002\/adhm.201801655","article-title":"Drug delivery strategies for the treatment of metabolic diseases","volume":"8","author":"Shi","year":"2019","journal-title":"Adv. Healthc. Mat."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/j.1468-2982.2007.01377.x","article-title":"Central mechanisms of controlled-release metoprolol in migraine: a doubleblind, placebo-controlled study","volume":"27","author":"Siniatchkin","year":"2007","journal-title":"Cephalalgia"},{"key":"B95","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00125-002-0800-2","article-title":"Vascular function, insulin resistance and fatty acids","volume":"45","author":"Steinberg","year":"2002","journal-title":"Diabetologia"},{"key":"B96","doi-asserted-by":"publisher","first-page":"C1687","DOI":"10.1152\/ajpcell.00282.2011","article-title":"Evolving insights regarding mechanisms for the inhibition of insulin release by norepinephrine and heterotrimeric g proteins","volume":"302","author":"Straub","year":"2012","journal-title":"Am. J. Physiology-Cell Physiology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.3390\/ijms21228507","article-title":"\u03b22-Adrenergic receptors increase cardiac fibroblast proliferation through the g\u03b1s\/ERK1\/2-dependent secretion of interleukin-6","volume":"21","author":"Tanner","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B98","first-page":"419","article-title":"Metabolic effects of an increase of sympathetic activity in healthy humans","volume":"19","author":"Tappy","year":"1995","journal-title":"J. Int. Assoc. Study Obes."},{"key":"B99","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10143-020-01277-4","article-title":"Beta-blockers and glioma: a systematic review of preclinical studies and clinical results","volume":"44","author":"Tewarie","year":"2020","journal-title":"Neurosurg. Rev."},{"key":"B100","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1038\/s41598-017-04762-x","article-title":"Heart failure and MEF2 transcriptome dynamics in response to \u03b2-blockers","volume":"7","author":"Tobin","year":"2017","journal-title":"Sci. Rep."},{"key":"B101","doi-asserted-by":"publisher","first-page":"919256","DOI":"10.1155\/2014\/919256","article-title":"Beta-blockers in the management of hypertension and\/or chronic kidney disease","volume":"2014","author":"Tomiyama","year":"2014","journal-title":"Int. J. Hypertens."},{"key":"B102","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00003495-198800366-00008","article-title":"Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine","volume":"36","author":"Tomlinson","year":"1988","journal-title":"Drugs"},{"key":"B103","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0014-2999(02)02648-1","article-title":"Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats","volume":"457","author":"Tsubokou","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/copd.s5511","article-title":"Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD","volume":"4","author":"van Gestel","year":"2009","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrd4477","article-title":"Managing diabetes with nanomedicine: challenges and opportunities","volume":"14","author":"Veiseh","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s11064-014-1367-2","article-title":"Carvedilol attenuates 6-hydroxydopamine-induced cell death in PC12 cells: involvement of Akt and Nrf2\/ARE pathways","volume":"39","author":"Wang","year":"2014","journal-title":"Neurochem. Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1172\/JCI107888","article-title":"Comparison of the effects on renin release of beta adrenergic antagonists with differing properties","volume":"54","author":"Weber","year":"1974","journal-title":"J. Clin. Invest."},{"key":"B109","doi-asserted-by":"publisher","first-page":"16735","DOI":"10.3390\/ijms242316735","article-title":"New insights into cardiovascular diseases treatment based on molecular targets","volume":"24","author":"Wojtasi\u0144ska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3389\/fimmu.2018.01920","article-title":"Repositioning of the \u03b2-blocker carvedilol as a novel autophagy inducer that inhibits the NLRP3 inflammasome","volume":"9","author":"Wong","year":"2018","journal-title":"Front. Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/cancers12051094","article-title":"Effects of beta-blockers on melanoma microenvironment and disease survival in human","volume":"12","author":"Wrobel","year":"2020","journal-title":"Cancers"},{"key":"B112","doi-asserted-by":"publisher","first-page":"9570616","DOI":"10.1155\/2019\/9570616","article-title":"Advanced glycation end products: potential mechanism and therapeutic target in cardiovascular complications under diabetes","volume":"12","author":"Yang","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"B113","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/antiox11040743","article-title":"Influence of diabetes-induced glycation and oxidative stress on the human rotator cuff","volume":"11","author":"Yoshikawa","year":"2022","journal-title":"Antioxidants"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.12998\/wjcc.v12.i9.1712","article-title":"Epinephrine also acts on beta cells and insulin secretion","volume":"12","author":"Zabuliene","year":"2024","journal-title":"World J. Clin. Cases"},{"key":"B115","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1742-7843.2012.00911.x","article-title":"Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension","volume":"111","author":"Zepeda","year":"2012","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biopha.2018.07.037","article-title":"Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/jcb.26292","article-title":"The role of \u03b2-adrenergic receptors and p38MAPK signaling pathways in physiological processes of cardiosphere-derived cells","volume":"119","author":"Zhang","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"B118","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/21655979.2021.2012627","article-title":"Carvedilol activates nuclear factor E2-related factor 2\/antioxidant response element pathway to inhibit oxidative stress and apoptosis of retinal pigment epithelial cells induced by high glucose","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioengineered"},{"key":"B119","doi-asserted-by":"publisher","first-page":"68314","DOI":"10.18632\/oncotarget.11599","article-title":"Propranolol induced g0\/g1\/s phase arrest and apoptosis in melanoma cells via akt\/mapk pathway","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"B120","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1253\/circj.cj-10-0110","article-title":"Pleiotropic effects of statins - basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circulation J."},{"key":"B121","doi-asserted-by":"publisher","first-page":"e97788","DOI":"10.1371\/journal.pone.0097788","article-title":"\u03b22-Adrenoceptor involved in smoking-induced airway mucus hypersecretion through \u03b2-arrestin-dependent signaling","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1489657\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T06:30:58Z","timestamp":1734676258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1489657\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":121,"alternative-id":["10.3389\/fphar.2024.1489657"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1489657","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"article-number":"1489657"}}